NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.710
+0.010 (1.43%)
At close: Nov 20, 2024, 4:00 PM
0.720
+0.010 (1.41%)
After-hours: Nov 20, 2024, 6:00 PM EST
NovaBay Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 13.8 | 14.69 | 14.37 | 10.18 | 9.92 | 6.56 | Upgrade
|
| Other Revenue | 0.05 | 0.04 | 0.03 | 0.02 | 0.02 | 0.04 | Upgrade
|
| Revenue | 13.84 | 14.73 | 14.4 | 10.2 | 9.93 | 6.6 | Upgrade
|
| Revenue Growth (YoY) | 15.40% | 2.24% | 41.16% | 2.72% | 50.54% | -47.24% | Upgrade
|
| Cost of Revenue | 5.97 | 6.83 | 6.62 | 3.69 | 3.97 | 1.74 | Upgrade
|
| Gross Profit | 7.87 | 7.9 | 7.78 | 6.52 | 5.96 | 4.86 | Upgrade
|
| Selling, General & Admin | 13.4 | 12.83 | 15.29 | 15.33 | 12.11 | 14.08 | Upgrade
|
| Research & Development | 0.06 | 0.07 | 0.17 | 0.04 | 0.29 | 0.18 | Upgrade
|
| Operating Expenses | 13.47 | 12.9 | 15.46 | 15.38 | 12.39 | 14.26 | Upgrade
|
| Operating Income | -5.59 | -5 | -7.68 | -8.86 | -6.43 | -9.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.3 | -2.08 | 3.25 | 3.04 | -5.51 | -0.25 | Upgrade
|
| EBT Excluding Unusual Items | -7.61 | -7.09 | -4.43 | -5.82 | -11.93 | -9.65 | Upgrade
|
| Impairment of Goodwill | -0.35 | -0.35 | -4.18 | - | - | - | Upgrade
|
| Asset Writedown | -2.25 | -2.25 | -2.56 | - | - | - | Upgrade
|
| Other Unusual Items | -0.03 | 0.04 | 0.56 | - | 0.9 | - | Upgrade
|
| Pretax Income | -11.1 | -9.64 | -10.61 | -5.82 | -11.03 | -9.65 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Net Income | -10.12 | -9.64 | -10.61 | -5.82 | -11.04 | -9.66 | Upgrade
|
| Preferred Dividends & Other Adjustments | 6.45 | 7.06 | 5.66 | 0.74 | - | 0.83 | Upgrade
|
| Net Income to Common | -16.57 | -16.7 | -16.27 | -6.56 | -11.04 | -10.49 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 1605.55% | 161.80% | 29.11% | 24.43% | 62.08% | 26.87% | Upgrade
|
| EPS (Basic) | -11.45 | -138.65 | -353.59 | -184.09 | -385.53 | -593.63 | Upgrade
|
| EPS (Diluted) | -11.45 | -138.65 | -353.59 | -184.09 | -385.53 | -593.63 | Upgrade
|
| Free Cash Flow | -4.74 | -4.15 | -6.77 | -9.24 | -4.75 | -7.95 | Upgrade
|
| Free Cash Flow Per Share | -3.28 | -34.46 | -147.09 | -259.45 | -165.79 | -449.90 | Upgrade
|
| Gross Margin | 56.87% | 53.61% | 54.02% | 63.85% | 60.04% | 73.66% | Upgrade
|
| Operating Margin | -40.41% | -33.97% | -53.32% | -86.85% | -64.69% | -142.45% | Upgrade
|
| Profit Margin | -119.65% | -113.38% | -112.92% | -64.28% | -111.12% | -158.92% | Upgrade
|
| Free Cash Flow Margin | -34.23% | -28.18% | -46.97% | -90.59% | -47.79% | -120.44% | Upgrade
|
| EBITDA | -5.4 | -4.8 | -7.2 | -8.74 | -6.38 | -9.34 | Upgrade
|
| EBITDA Margin | -38.99% | -32.60% | -49.97% | -85.68% | -64.17% | -141.46% | Upgrade
|
| D&A For EBITDA | 0.2 | 0.2 | 0.48 | 0.12 | 0.05 | 0.07 | Upgrade
|
| EBIT | -5.59 | -5 | -7.68 | -8.86 | -6.43 | -9.4 | Upgrade
|
| EBIT Margin | -40.41% | -33.97% | -53.32% | -86.85% | -64.69% | -142.45% | Upgrade
|
| Revenue as Reported | 13.84 | 14.73 | 14.4 | 10.2 | 9.93 | 6.6 | Upgrade
|
| Advertising Expenses | - | 1.1 | 2 | 3.2 | 1.7 | 0.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.